DiGeorge Syndrome Critical Region Gene 8 (DGCR8) (N-Term) Peptide
Quick Overview for DiGeorge Syndrome Critical Region Gene 8 (DGCR8) (N-Term) Peptide (ABIN8098883)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- DGCR8 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-DGCR8 antibody ( ARP40984_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
-
Background
-
Targeted Subunit: DGCR8
Background Information: DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Alternative Symbols: C22orf12, DGCRK6, Gy1, pasha
-
Molecular Weight
- 85kDa
-
Gene ID
- 54487
-
NCBI Accession
- NP_073557
-
UniProt
- Q8WYQ5
Target
-
